Sundry Images
Merck (NYSE:MRK) mentioned it expects its top-selling drug, Keytruda, to be chosen by the U.S. authorities for worth setting negotiations subsequent 12 months below the Inflation Discount Act.
In a submitting with the SEC, Merck (NYSE:MRK) famous that the U.S. Division
